These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7024638)

  • 21. Detection of Cannabinoids by ELISA and GC-MS Methods in a Hair Sample Previously Used to Detect Other Drugs of Abuse.
    Tassoni G; Cippitelli M; Ottaviani G; Froldi R; Cingolani M
    J Anal Toxicol; 2016 Jul; 40(6):408-13. PubMed ID: 26487640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of drugs in saliva of impaired drivers.
    Peel HW; Perrigo BJ; Mikhael NZ
    J Forensic Sci; 1984 Jan; 29(1):185-9. PubMed ID: 6366113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the Abbott ADx Amphetamine/Methamphetamine II abused drug assay: comparison to TDx, EMIT, and GC/MS methods.
    Przekop MA; Manno JE; Kunsman GW; Cockerham KR; Manno BR
    J Anal Toxicol; 1991; 15(6):323-6. PubMed ID: 1779660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of past and recurrent marijuana use by a modified GC/MS procedure.
    Joern WA
    J Anal Toxicol; 1987; 11(2):49-52. PubMed ID: 3033397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison of various immunologic methods with a GC-MS analysis in cannabinoid detection in urine].
    Käferstein H; Sticht G; Staak M
    Beitr Gerichtl Med; 1989; 47():115-22. PubMed ID: 2684146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection and interpretation of lysergic acid diethylamide results by immunoassay screening of urine in various testing groups.
    Wu AH; Feng YJ; Pajor A; Gornet TG; Wong SS; Forte E; Brown J
    J Anal Toxicol; 1997; 21(3):181-4. PubMed ID: 9171199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug screening and confirmation by GC-MS: comparison of EMIT II and Online KIMS against 10 drugs between US and England laboratories.
    Lu NT; Taylor BG
    Forensic Sci Int; 2006 Mar; 157(2-3):106-16. PubMed ID: 15899564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GC/MS and EMIT analyses for delta 9-tetrahydrocannabinol metabolites in plasma and urine of human subjects.
    McBurney LJ; Bobbie BA; Sepp LA
    J Anal Toxicol; 1986; 10(2):56-64. PubMed ID: 3009969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laboratory evaluation of immunoassay kits for the detection of cannabinoids in biological fluids.
    Peat MA; Finkle BS; Deyman ME
    NIDA Res Monogr; 1982; 42():85-98. PubMed ID: 6817140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. delta 9-Tetrahydrocannabinol by GLC-MS validated radioimmunoassays of hemolyzed blood or serum.
    Yeager EP; Goebelsmann U; Soares JR; Grant JD; Gross SJ
    J Anal Toxicol; 1981; 5(2):81-4. PubMed ID: 6264224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Confirmation of EMIT cannabinoid assay results by bonded phase adsorption with thin layer chromatography.
    Willson NJ; Kogan MJ; Pierson DJ; Newman E
    J Toxicol Clin Toxicol; 1983 Jul; 20(5):465-73. PubMed ID: 6366244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection and confirmation of cocaine use by chromatographic analysis for methylecgonine in urine.
    Clark DR; Hajar TM
    Clin Chem; 1987 Jan; 33(1):118-9. PubMed ID: 3542285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection and confirmation of urinary cannabinoids.
    Sutheimer CA; Yarborough R; Hepler BR; Sunshine I
    J Anal Toxicol; 1985; 9(4):156-60. PubMed ID: 4033071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance of the Emit® II Plus 6-Acetylmorphine Assay on the Viva-E® analyzer.
    Yau H; Dominowski A; Schaible C; Siefring G; Morjana N
    Forensic Sci Int; 2012 Jul; 220(1-3):97-102. PubMed ID: 22410425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison of the MTP immunoassay with EMIT in blood screening for drugs].
    Käferstein H; Sticht G
    Arch Kriminol; 1998; 202(5-6):165-72. PubMed ID: 10023491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utilization of a detection level of 25ng/mL for cannabinoids in urine using a CEDIA THCPLUS immunoassay: application of this cut-off to urines of school children.
    Madhavaram H; Couch RA
    Forensic Sci Int; 2010 May; 198(1-3):28-30. PubMed ID: 20219301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of a fluorescent immunoassay with an enzyme immunoassay and a radioimmunoassay for gentamicin.
    Lau AH; Chow-Tung E
    Am J Hosp Pharm; 1984 Dec; 41(12):2647-50. PubMed ID: 6393760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary screening for methylphenidate (Ritalin) abuse: a comparison of liquid chromatography-tandem mass spectrometry, gas chromatography-mass spectrometry, and immunoassay methods.
    Eichhorst J; Etter M; Lepage J; Lehotay DC
    Clin Biochem; 2004 Mar; 37(3):175-83. PubMed ID: 14972638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. False negative GC/MS assay for carboxy THC due to ibuprofen interference.
    Brunk SD
    J Anal Toxicol; 1988; 12(5):290-1. PubMed ID: 2852278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cannabinoids in hair: strategy to prove marijuana/hashish consumption.
    Uhl M; Sachs H
    Forensic Sci Int; 2004 Oct; 145(2-3):143-7. PubMed ID: 15451086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.